News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Lung Cancer Considered’s new episode on Tumor Treating Fields – IASLC
IASLC/X
Dec 25, 2024, 13:45

Lung Cancer Considered’s new episode on Tumor Treating Fields – IASLC

IASLC posted on X:

“New episode of Lung Cancer Considered! Narjust Florez and Leal Ticiana dive into Tumor Treating Fields (TTFields), an FDA-approved therapy disrupting cancer cell division.

Learn about the Phase III LUNAR study!

Listen now.”

cancer IASLC Leal Ticiana LUNAR study Lung Cancer Considered Narjust Florez NSCLC OncoDaily Oncology Tumor Treating Fields
Special Coverage
Drugs
Apr 25, 2025, 05:55
Durvalumab (Imfinzi): What patients need to know?
Blog
Apr 25, 2025, 05:27
Applications are still open for The SIOG Advanced Course 2025
Career
Apr 25, 2025, 04:25
Cary Adams endorses Dato' Dr Saunthari Somasundaram as the candidate for the President-elect for the NCD Alliance
Oncolibrary
Apr 25, 2025, 02:46
FDA Approves Penpulimab for Recurrent or Metastatic Non-Keratinizing Nasopharyngeal Carcinoma
Career
Apr 24, 2025, 21:39
Triparna Sen: I am thrilled and humbled to be nominated as a candidate for the IASLC Board of Directors
Blog
Apr 24, 2025, 21:05
Liz O’Riordan: 25 things I wish I had known before I got breast cancer
Blog
Apr 24, 2025, 20:53
Signing Ceremony of MoU Between Doha University for Science and Technology and Qatar Cancer Society
Blog
Apr 24, 2025, 20:40
Yan Leyfman: How AI is transforming cancer care - from improving diagnosis to reducing disparities
Insight
Apr 24, 2025, 20:28
Fernando Campos: We revealed a harsh Brazilian reality in Sarcoma Study
Insight
Apr 24, 2025, 19:38
George Vlachogiannis: Black patients were less likely to receive nephrectomy compared to non-Hispanic White patients
Blog
Apr 24, 2025, 18:30
Paolo Tarantino: Recent ADCs took a median time of 7 years from clinical introduction to approval
Blog
Apr 24, 2025, 17:56
Milestones from Philippine Cervical Cancer Elimination Operational Plan Workshop - APAC Women's Cancer Coalition